Detalhe da pesquisa
1.
MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.
Br J Haematol
; 153(6): 753-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21496004
2.
BRAF fusions identified in melanomas have variable treatment responses and phenotypes.
Oncogene
; 38(8): 1296-1308, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254212
3.
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.
Cell Death Dis
; 9(9): 907, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185782
4.
ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.
Mol Cancer Ther
; 17(1): 222-231, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054983